Webinare

Zoonotic viruses are emerging in the human population and threaten the health of many people. SARS-CoV-2 is the latest and most prominent example of today. The current situation of the pandemic is explained and different assays and strategies of testing will be elucidated. Pros and cons of different approaches will be discussed with the audience.

Based on practicle examples from the DiagnostikNet-BB we give you an overview of biomarkers and innovative testsystems for diagnostics, prognosis and monitoring of autoimmune diseases. Current scientific topics will also be highlighted: COVID-19 intensive care patients occasionally develop neurological symptoms. According to recent studies, autoimmune mechanisms are involved.

With the introduction of the In Vitro Diagnostics Regulation (IVDR 2017/746), requirements for the performance rating are increasing. We will show you how diagnostic manufacturers can prove the clinical benefit, can carry out performance-based studies and do post-market surveillance. Our network will support you with various services – let’s face it together!

The presentation outlines how teams should be set up internally, what preparations should be made now and how should the Notified Bodies be addressed? Which changes are to be expected in the near future and what do companies have to prepare for? Selected focal points are: Traceability, vigilance and the European database.